Histologic heterogeneity predicts patient prognosis of HER2‐positive metastatic breast cancer: A retrospective study based on SEER database

Histologic heterogeneity predicts patient prognosis of HER2‐positive metastatic breast cancer: A retrospective study based on SEER database

Abstract Background Human epidermal growth factor receptor 2‐positive (HER2+) metastatic breast cancer (MBC) is a subtype of breast cancer with a worse prognosis. Little is known about the relationship between histology and prognosis among different distant metastasis sites (DMS). Our aims were to e...

Full description

Bibliographic Details
Main Authors: Yajie Wang, Yiran Liang, Fangzhou Ye, Dan Luo, Yuhan Jin, Yaming Li, Wenjing Zhao, Bing Chen, Lijuan Wang, Qifeng Yang
Format: Article
Language:English
Published: Wiley 2023-09-01
Series:Cancer Medicine
Subjects:
HER2‐positive breast cancer
histologic heterogeneity
preferential distant metastasis
prognosis
SEER database
Online Access:https://doi.org/10.1002/cam4.6469

Internet

https://doi.org/10.1002/cam4.6469

Similar Items